stocks logo

BRKR Valuation

Bruker Corp
$
34.120
+1.76(5.439%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings

BRKR Relative Valuation

BRKR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BRKR is overvalued; if below, it's undervalued.

Historical Valuation

Bruker Corp (BRKR) is now in the Undervalued zone, suggesting that its current forward PE ratio of 14.34 is considered Undervalued compared with the five-year average of 27.31. The fair price of Bruker Corp (BRKR) is between 47.76 to 70.97 according to relative valuation methord. Compared to the current price of 33.50 USD , Bruker Corp is Undervalued By 29.86%.
Relative Value
Fair Zone
47.76-70.97
Current Price:33.50
29.86%
Undervalued
14.34
PE
1Y
3Y
5Y
Trailing
Forward
12.05
EV/EBITDA
Bruker Corp. (BRKR) has a current EV/EBITDA of 12.05. The 5-year average EV/EBITDA is 17.95. The thresholds are as follows: Strongly Undervalued below 11.67, Undervalued between 11.67 and 14.81, Fairly Valued between 21.09 and 14.81, Overvalued between 21.09 and 24.23, and Strongly Overvalued above 24.23. The current Forward EV/EBITDA of 12.05 falls within the Undervalued range.
14.54
EV/EBIT
Bruker Corp. (BRKR) has a current EV/EBIT of 14.54. The 5-year average EV/EBIT is 20.11. The thresholds are as follows: Strongly Undervalued below 13.44, Undervalued between 13.44 and 16.78, Fairly Valued between 23.44 and 16.78, Overvalued between 23.44 and 26.77, and Strongly Overvalued above 26.77. The current Forward EV/EBIT of 14.54 falls within the Undervalued range.
1.34
PS
Bruker Corp. (BRKR) has a current PS of 1.34. The 5-year average PS is 3.42. The thresholds are as follows: Strongly Undervalued below 1.65, Undervalued between 1.65 and 2.54, Fairly Valued between 4.31 and 2.54, Overvalued between 4.31 and 5.20, and Strongly Overvalued above 5.20. The current Forward PS of 1.34 falls within the Strongly Undervalued range.
14.02
P/OCF
Bruker Corp. (BRKR) has a current P/OCF of 14.02. The 5-year average P/OCF is 25.16. The thresholds are as follows: Strongly Undervalued below 11.97, Undervalued between 11.97 and 18.56, Fairly Valued between 31.75 and 18.56, Overvalued between 31.75 and 38.34, and Strongly Overvalued above 38.34. The current Forward P/OCF of 14.02 falls within the Undervalued range.
19.18
P/FCF
Bruker Corp. (BRKR) has a current P/FCF of 19.18. The 5-year average P/FCF is 35.91. The thresholds are as follows: Strongly Undervalued below 10.44, Undervalued between 10.44 and 23.18, Fairly Valued between 48.65 and 23.18, Overvalued between 48.65 and 61.39, and Strongly Overvalued above 61.39. The current Forward P/FCF of 19.18 falls within the Undervalued range.
Bruker Corp (BRKR) has a current Price-to-Book (P/B) ratio of 2.59. Compared to its 3-year average P/B ratio of 7.13 , the current P/B ratio is approximately -63.68% higher. Relative to its 5-year average P/B ratio of 8.23, the current P/B ratio is about -68.56% higher. Bruker Corp (BRKR) has a Forward Free Cash Flow (FCF) yield of approximately 1.06%. Compared to its 3-year average FCF yield of 1.83%, the current FCF yield is approximately -42.22% lower. Relative to its 5-year average FCF yield of 1.99% , the current FCF yield is about -47.00% lower.
2.59
P/B
Median3y
7.13
Median5y
8.23
1.06
FCF Yield
Median3y
1.83
Median5y
1.99

Competitors Valuation Multiple

The average P/S ratio for BRKR's competitors is 3.16, providing a benchmark for relative valuation. Bruker Corp Corp (BRKR) exhibits a P/S ratio of 1.34, which is -57.54% above the industry average. Given its robust revenue growth of -0.41%, this premium appears unsustainable.

Performance Decomposition

1Y
3Y
5Y
Market capitalization of BRKR decreased by 51.76% over the past 1 year. The primary factor behind the change was an decrease in Revenue Growth from 800.70M to 797.40M.
The secondary factor is the P/E Change, contributed -7.14%to the performance.
Overall, the performance of BRKR in the past 1 year is driven by Revenue Growth. Which is more sustainable.
-0.41%
800.70M → 797.40M
Revenue Growth
+
-44.21%
0.95 → 0.53
Margin Expansion
+
-7.14%
63.65 → 59.10
P/E Change
=
-51.76%
67.08 → 32.36
Mkt Cap Growth

FAQ

arrow icon

Is Bruker Corp (BRKR) currently overvalued or undervalued?

Bruker Corp (BRKR) is now in the Undervalued zone, suggesting that its current forward PE ratio of 14.34 is considered Undervalued compared with the five-year average of 27.31. The fair price of Bruker Corp (BRKR) is between 47.76 to 70.97 according to relative valuation methord. Compared to the current price of 33.50 USD , Bruker Corp is Undervalued By 29.86% .
arrow icon

What is Bruker Corp (BRKR) fair value?

arrow icon

How does BRKR's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Bruker Corp (BRKR) as of Aug 13 2025?

arrow icon

What is the current FCF Yield for Bruker Corp (BRKR) as of Aug 13 2025?

arrow icon

What is the current Forward P/E ratio for Bruker Corp (BRKR) as of Aug 13 2025?

arrow icon

What is the current Forward P/S ratio for Bruker Corp (BRKR) as of Aug 13 2025?